• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.13% Nasdaq Up 0.70%

    Celgene Corporation (CELG)

    -NasdaqGS
    113.35 Up 3.75(3.42%) Dec 26, 4:00PM EST
    |After Hours : 113.75 Up 0.40 (0.35%) Dec 26, 6:54PM EST
    Add to Portfolio
    Prev Close:109.60
    Open:111.20
    Bid:112.36 x 100
    Ask:N/A
    1y Target Est:117.59
    Beta:2
    Next Earnings Date:29-Jan-15CELG Earnings announcement
    Day's Range:110.56 - 113.91
    52wk Range:66.85 - 119.84
    Volume:4,670,519
    Avg Vol (3m):5,499,260
    Market Cap:90.53B
    P/E (ttm):59.38
    EPS (ttm):1.91
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for CELG

    Comparison

    Symbol% ChgMkt Cap
    CELGUp 3.42%90.53B
    JNJUp 0.45%294.07B

    Key Statistics

    Forward P/E (1 yr):23.32
    P/S (ttm):11.92
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :3.68
    Quarterly EPS Est (Dec-14) :1.00
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):1.20

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Celgene Corporation, a biopharmaceutical company, discovers, develops, and commercializes therapies to treat cancer and immune-inflammatory related diseases in the United States and internationally. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback